AKUMS DRUGS & PHARMACEUTICALS
Back to All Ratios
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 8.35 | 0.02 | 2.68 | -6.83 | 4.52 |
What is the latest Profit After Tax (PAT) Margin ratio of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 8.35 |
| Mar2024 | 0.02 |
| Mar2023 | 2.68 |
| Mar2022 | -6.83 |
| Mar2021 | 4.52 |
How is Profit After Tax (PAT) Margin of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 8.35 | 41,650.00 | |
| Mar2024 | 0.02 | -99.25 | |
| Mar2023 | 2.68 | Positive | |
| Mar2022 | -6.83 | Negative | |
| Mar2021 | 4.52 | - | |
Other Financial Ratios of AKUMS DRUGS & PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹7,984.1 Cr | 2.1% | 4.8% | 3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,150.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,129.0 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,312.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,445.2 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,210.2 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 2.1% |
4.8% |
3.7% |
| SENSEX | 7.8% |
-2% |
0.2% |
You may also like the below Video Courses